New Method for Cell Cryopreservation

Information

  • Research Project
  • 7404376
  • ApplicationId
    7404376
  • Core Project Number
    R43GM083523
  • Full Project Number
    1R43GM083523-01
  • Serial Number
    83523
  • FOA Number
    PA-07-80
  • Sub Project Id
  • Project Start Date
    2/1/2008 - 17 years ago
  • Project End Date
    1/31/2009 - 16 years ago
  • Program Officer Name
    HEART, LUNG, AND BLOOD INST., NATIONAL
  • Budget Start Date
    2/1/2008 - 17 years ago
  • Budget End Date
    1/31/2009 - 16 years ago
  • Fiscal Year
    2008
  • Support Year
    1
  • Suffix
  • Award Notice Date
    1/17/2008 - 17 years ago
Organizations

New Method for Cell Cryopreservation

[unreadable] DESCRIPTION (provided by applicant): Human bone marrow (BM), peripheral blood stem cells (PBSC), and cord blood stem cells (CBSC) are widely used for transplantation in cancer treatment. Patients with leukemia often receive very high doses of chemotherapy and/or radiation therapy which severely damages or destroys bone marrow. Transplantation of BM, PBSC and CBSC can replace stem cells that were destroyed by these treatments and healthy, transplanted stem cells can then restore the ability of bone marrow to produce blood cells in vivo. BM and PBSC are the most frequently used cell types for treating leukemia and lymphoma, and cancers such as multiple myeloma and neuroblastoma (a cancer that arises in immature nerve cells which primarily affects infants and children). Improved methods for sample preparation, and long term storage and cryopreservation of bone marrow and blood samples are urgently needed. After harvesting BM or collecting PBSC and CBSC, samples are processed and frozen to maintain viability until transplantation. Stored blood samples often exhibit problems including cell loss and cell clumping. As the number of transplants continues to increase, research efforts by both public and commercial blood banks aimed at increasing cell viability and recovery after cryopreservation have increased dramatically. Using single cell gel microdrop (GMD) encapsulation technology, this research will develop a method for increasing cell viability and recovery after cryopreservation. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99512
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:99512\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ONE CELL SYSTEMS, INC
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02139
  • Organization District
    UNITED STATES